John Glenn

Insider Reports History

Location
Orlando, FL
Signature
/s/ John Glenn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Glenn:

Form 4 holding CHIEF FINANCIAL OFFICER

IRADIMED CORP

Security class
Restricted Stock Units
Shares / value
8,907
Estimated value
$2,194,711
Report date
03 Mar 2026
Price
$54.18
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF FINANCIAL OFFICER

IRADIMED CORP

Security class
Performance-based Restricted Stock Units
Shares / value
0
Estimated value
$1,252,580
Report date
07 Dec 2025
Price
$54.18
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF FINANCIAL OFFICER

IRADIMED CORP

Security class
Common Stock
Shares / value
8,460
Estimated value
$823,834
Report date
11 Dec 2025
Price
$97.38
Ownership
Direct
Form 4 holding Chief Financial Officer

EKSO BIONICS HOLDINGS, INC.

Security class
Common Stock
Shares / value
35,130
Estimated value
$34,975
Report date
22 Mar 2022
Price
$0.9956
Ownership
Direct

Insider Reports Filed by John Glenn

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .